We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA Biosensor Enables Early Diagnosis of Cervical Cancer

By LabMedica International staff writers
Posted on 21 Dec 2023

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community. More...

These nanosheets are formed through the stacking of S–Mo–S layers that are held together by Van der Waals forces. MoS2's distinctive structural, optical, thermal, and electrochemical attributes have paved the way for research in diverse domains, including biomolecule sensing, optoelectronics, energy storage, and more. Historically, carbon nanostructures have been used as an immobilization platform for DNA. To replace carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 must be improved significantly.

To tackle this challenge, researchers at Chung-Ang University (Seoul, South Korea) have devised an electrochemical DNA biosensor using a composite of graphitic nano-onions and MoS2 nanosheets. This biosensor shows promise in detecting human papillomavirus (HPV) types 16 and 18, offering the potential for early cervical cancer diagnosis. The team measured the biosensor's sensitivity to these HPV types using the differential pulse voltammetry (DPV) technique in conjunction with methylene blue (MB) as a redox indicator. They observed that the nano-onion/MoS2 nanosheet composite electrode demonstrated higher current peaks than its MoS2-only counterpart, suggesting enhanced conductive electron transfer facilitated by the nano-onions.

This enhancement led to the effective and specific detection of target DNAs from HPV-16 and HPV-18 Siha and Hela cancer cell lines. As a result, MoS2 nanosheets with improved electrical conductivity, when combined with nano-onions, have shown potential as a robust platform for creating electrochemical biosensors that can efficiently diagnose various health conditions, including cervical cancer. Moreover, the integration of nano-onions or nanodiamonds with various organic biomaterials could lead to advancements in chemical functionality, electron transfer conductivity, light absorption, and more. These developments hold promise for groundbreaking applications in disease sensing, targeted drug delivery, and biomedical imaging and diagnostics.

Related Links:
Chung-Ang University 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.